Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.

about

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.New Ways to Treat Tuberculosis Using Dendrimers as Nanocarriers

P2860

Q55650643-16F47768-2855-4733-ABF6-5B0E086C3224 Q57174607-0B4F7BD7-1AE4-41A7-904E-E81854E42ECB

P2860

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.

Item

http://www.wikidata.org/entity/Q40113350

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Bedaquiline and Delamanid Comb ...... y Drug-Resistant Tuberculosis.

@en

type

Item

label

Bedaquiline and Delamanid Comb ...... y Drug-Resistant Tuberculosis.

@en

prefLabel

Bedaquiline and Delamanid Comb ...... y Drug-Resistant Tuberculosis.

@en

P1476

Bedaquiline and Delamanid Comb ...... y Drug-Resistant Tuberculosis.

@en

P2093

Emanuele Pontali

http://www.w3.org/2001/XMLSchema#string

Giovanni Sotgiu

http://www.w3.org/2001/XMLSchema#string

Jai Mullerpattan

http://www.w3.org/2001/XMLSchema#string

Jan-Willem Alffenaar

http://www.w3.org/2001/XMLSchema#string

Lia D'Ambrosio

http://www.w3.org/2001/XMLSchema#string

Onno Akkerman

http://www.w3.org/2001/XMLSchema#string

Rohit Amale

http://www.w3.org/2001/XMLSchema#string

Shashank Ganatra

http://www.w3.org/2001/XMLSchema#string

Sonam Topgyal

http://www.w3.org/2001/XMLSchema#string

Tsetan Dorji Sadutshang

http://www.w3.org/2001/XMLSchema#string

P2860

Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation

World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline.

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine.

Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline.

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine.

Bedaquiline plus delamanid for XDR tuberculosis.

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence.

P31

scholarly article

P356

10.3201/EID2310.170834

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Battista Migliori

Simon Tiberi

R Centis

Andrey Maryandyshev

P577

2017-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28758888

http://www.w3.org/2001/XMLSchema#string

P932

5621558

http://www.w3.org/2001/XMLSchema#string

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.

about

P2860

P2860

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932